Mounjaro (tirzepatide)
It is an innovative medication that’s been approved for managing type 2 diabetes and supporting weight loss. In India, it’s becoming a popular choice for those dealing with obesity and metabolic issues. This detailed guide explores the benefits of Mounjaro, its side effects, pricing, availability, and how it stacks up against Ozempic (semaglutide), another well-known GLP-1 receptor agonist.
What Is Mounjaro?
Mounjaro is a once-a-week injectable medication created by Eli Lilly. It acts as a dual GIP and GLP-1 receptor agonist, mimicking the actions of two natural hormones that help control blood sugar and appetite. By boosting insulin secretion and slowing down gastric emptying, Mounjaro aids in managing blood sugar levels and promotes a feeling of fullness, which can lead to eating less.
Mounjaro Injection for Weight Loss Benefits
Clinical studies have shown that Mounjaro can result in significant weight loss. The SURMOUNT-1 trial found that participants without diabetes who took Mounjaro lost an average of 15% of their body weight over 72 weeks. Moreover, a study published in The Lancet emphasized its effectiveness in treating type 2 diabetes and obesity in children aged 10 and older.
Mounjaro vs. Ozempic: A Comparative Overview
Is Mounjaro better than Ozempic?
Feature |
Mounjaro (Tirzepatide) |
Ozempic (Semaglutide) |
|
Mechanism of
Action |
Dual GIP and
GLP-1 receptor agonist |
GLP-1
receptor agonist |
|
Weight Loss
Efficacy |
Higher
average weight loss |
Moderate
weight loss |
|
Cardiovascular
Benefits |
Under
investigation |
Proven
reduction in heart risks |
|
Dosing |
Weekly
injection |
Weekly
injection |
|
Cost (India) |
₹3,500–₹25,781
per month |
Not yet
available |
While both medications are effective for managing type 2 diabetes and promoting weight loss, Mounjaro's dual-action mechanism may offer enhanced efficacy. However, Ozempic has established cardiovascular benefits, which Mounjaro has not yet been proven to provide
Mounjaro injection side effects :
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
Most of these side effects are usually mild and tend to fade as your body gets used to the medication. However, there are some serious side effects to be aware of, including:
- Pancreatitis
- Kidney issues
- Thyroid tumors (as seen in animal studies)
It's really important to talk to your healthcare provider before starting Mounjaro to make sure it's the right fit for your health needs.
Who Should Avoid Mounjaro?
Mounjaro isn't recommended for people who have:
- A personal or family history of medullary thyroid
carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
- A history of pancreatitis
- Severe gastrointestinal issues
- An allergy to tirzepatide or any of its ingredients
- Pregnancy or breastfeeding
Always keep your healthcare provider updated on your medical history to see if Mounjaro is a good option for you.
Mounjaro Injection Pricing in India
Eli Lilly introduced Mounjaro injection in India in August 2025,
available in both vial and KwikPen formats. Here’s a breakdown of the prices:
Vial Prices (Weekly Supply):
- 2.5 mg: ₹3,281
- 5 mg: ₹4,101
KwikPen Prices (Monthly Supply):
- 2.5 mg: ₹13,125
- 5 mg: ₹16,406
- 7.5 mg: ₹20,625
- 10 mg: ₹20,625
- 12.5 mg: ₹25,781
- 15 mg: ₹25,781
These prices reflect the cost for a month’s supply, with each pen containing four fixed weekly doses.
Availability in India
You can find Mounjaro at various pharmacies and healthcare providers across India. It’s a good idea to consult with a healthcare professional to get a prescription and advice on where to buy the medication.
Conclusion
Mounjaro offers a promising solution for those in India
looking to effectively manage type 2 diabetes and lose weight. Its dual-action
mechanism provides better efficacy compared to other medications like Ozempic.
However, it’s essential to discuss potential side effects, costs, and your individual
health conditions should be discussed with a healthcare provider to determine
the most appropriate treatment plan.

Comments
Post a Comment